Form 4 for PCVX Vaxcyte, Inc.
Accepted 2023-12-11 00:00:00 ET · period of report 2023-12-07 · accession 0001209191-23-058061 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-11 | 2023-12-07 | PCVX | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | M - OptEx | $21.41 | +10.0K | 31.0K | +48% | +$214.1K |
| D | 2023-12-11 | 2023-12-07 | PCVX | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | F - Tax | $56.78 | -325 | 20.7K | -2% | -$18.5K |
| D | 2023-12-11 | 2023-12-07 | PCVX | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | S - Sale+OE | $56.50 | -10.0K | 21.0K | -32% | -$565.0K |
| D | 2023-12-11 | 2023-12-07 | PCVX | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | M - OptEx | $0.00 | +10.0K | 195.0K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-07 | M | A | 10,000 | $21.41 | 31,035 | D | — | — | (F1) Includes 548 shares acquired under the Vaxcyte, Inc. Employee Stock Purchase Plan on November 17, 2023. |
| 2 | Common | Common Stock | 2023-12-07 | F | D | 325 | $56.78 | 20,710 | D | — | — | (F3) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units. |
| 3 | Common | Common Stock | 2023-12-07 | S | D | 10,000 | $56.50 | 21,035 | D | — | — | |
| 4 | Derivative | Stock Option (right to buy) | 2023-12-07 | M | A | 10,000 | $0.00 | 195,000 | D | $21.41 · — to 2032-05-08 | 10,000 Common Stock | (F4) 1/4 of the shares subject to the option shall vest on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date. |